Gilbert Deray
Overview
Explore the profile of Gilbert Deray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
209
Citations
2454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kreutz R, Deray G, Floege J, Gwechenberger M, Hahn K, Luft A, et al.
JACC Adv
. 2024 Jun;
3(2):100813.
PMID: 38939389
Background: Treatment with vitamin K antagonists (VKAs) has been linked to worsening of kidney function in patients with atrial fibrillation (AF). Objectives: XARENO (Factor XA-inhibition in RENal patients with non-valvular...
2.
Kreutz R, Deray G, Floege J, Gwechenberger M, Hahn K, Luft A, et al.
TH Open
. 2024 Feb;
8(1):e106-e113.
PMID: 38406259
Patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are at high risk for both thromboembolism and bleeding events. The latter induces a potential reason for withholding oral anticoagulation...
3.
Tostivint I, Araman R, Castiglione V, Alkouri R, Vargas-Poussou R, Conort P, et al.
Urolithiasis
. 2022 Feb;
50(3):319-331.
PMID: 35224662
Genetic renal phosphate leak is one of the rare disorders in recurrent stone formers with absorptive hypercalciuria. Diagnosis and appropriate management may change the life of patients. To provide answers...
4.
Aloy B, Janus N, Isnard-Bagnis C, Deray G, Launay-Vacher V
Nephrol Ther
. 2021 Nov;
17(7):553-563.
PMID: 34802974
The renal toxicity of anticancer drugs is a clinical challenge because of the intrinsic toxicity of some anticancer drugs and because the cancer itself. Indeed, cancer patients are exposed to...
5.
Alafaleq M, Freund R, Penet M, Fardeau C, Isnard-Bagnis C, Tezenas du Montcel S, et al.
Eye (Lond)
. 2021 Oct;
36(11):2144-2150.
PMID: 34718340
Objective: A non-interventional, longitudinal, retrospective follow-up study to assess CsA-induced nephrotoxicity (IN) and its reversibility after withdrawal in patients exhibiting a bilateral chronic posterior uveitis (CPU) associated with cystoid macular...
6.
Kreutz R, Deray G, Floege J, Gwechenberger M, Hahn K, Luft A, et al.
Kardiol Pol
. 2021 Oct;
79(11):1265-1267.
PMID: 34643264
No abstract available.
7.
Michallet M, Sobh M, Deray G, Gangneux J, Pigneux A, Larrey D, et al.
Clin Lymphoma Myeloma Leuk
. 2020 Sep;
21(1):35-45.
PMID: 32958431
We have presented a practical guide developed by a working group of experts in infectious diseases and hematology to summarize the different recommendations issued by the different international groups on...
8.
Berdougo J, Deloriere E, Deray G, Launay-Vacher V
Nephrol Ther
. 2020 Jan;
16(1):59-64.
PMID: 31987727
Introduction: The French National Authority for health recommends that the adjustment of the dosage of drugs in patients with renal insufficiency be carried out on the basis of an estimate...
9.
Delma S, Isnard-Bagnis C, Deray G, Barthelemy R, Mercadal L, Desbuissons G
Nephrol Ther
. 2018 Nov;
14(7):548-553.
PMID: 30385137
Background: Calciphylaxis or calcific uremic arteriolopathy (CUA) is a cutaneous disease with ulcerations secondary to calcification of cutaneous and subcutaneous small arteries and arterioles. It is a rare but severe...
10.
Janus N, Launay-Vacher V, Deray G
Nephrol Ther
. 2018 Oct;
14(6):484-490.
PMID: 30301611
The development of interventional radiology techniques regularly exposes patients to the potential renal toxocity of iodinated contrast media. Faced with this risk of nephrotoxicity, gadolinium-based contrast agents have long been...